bibliographic entry 1463590 [be/1463590]
https://w3id.org/oc/corpus/be/1463590

is a
content
  • Yang, J.C-H, Wu, Y-L, Schuler, M, Sebastian, M, Popat, S, Yamamoto, N, Zhou, C, Hu, C-P, O’Byrne, K, Feng, J. Afatinib, versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): Analysis of overall survival data from two randomised, phase 3 trials, Lancet Oncol, 2015, 16, 141, 151, DOI: 10.1016/S1470-2045(14)71173-8, PMID: 25589191
references